Protective effects of the wild blackberry on cyclosporine-induced renal injury in rats: implications for veterinary and agricultural toxicology
DOI:
https://doi.org/10.59658/jkas.v12i3.4352Keywords:
Ciclosporin, Rubus ulmifolius, kidney tissueAbstract
Immunosuppressant nephrotoxicity limits safe use. This study tested whether an aqueous extract of Rubus ulmifolius protects against cyclosporine-induced renal injury in rats, of clinical, agricultural, and veterinary relevance worldwide. Twenty-four male rats were randomized into four groups (n=6): G1 vehicle; G2 cyclosporine 0.2 mg/kg by oral gavage every other day; G3 extract 400 mg/kg daily for 30 days; G4 extract 400 mg/kg daily with Cyclosporine 4 h later on alternate days. Serum urea, creatinine, albumin, globulin, and total protein were assessed; kidneys were examined histologically. Biochemical assays used standard colorimetric methods, and statistical significance was set at P<0.05. Cyclosporine increased urea and creatinine and decreased albumin, globulin, and total protein versus G1. Extract alone matched control with no observable adverse effects. Pre-treatment prevented cyclosporine changes, normalizing values; G4 remained comparable to G1. Histology: G2 showed glomerular atrophy, widened Bowman’s space, tubular sloughing, congestion, hemorrhage, inflammatory infiltration, and tubular degeneration/necrosis; G4 appeared near normal with preserved glomeruli and tubules. R. ulmifolius aqueous extract confers renoprotection against cyclosporine nephrotoxicity in male rats, normalizing renal biomarkers and preserving histology. These findings support its potential as a phytogenic adjunct to mitigate drug-induced kidney injury; dose–response and mechanistic studies are warranted.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Copyright (c) 2024 is the Author's article. Published by the Journal of Kerbala for Agricultural Sciences under a CC BY 4.0 license

This work is licensed under a Creative Commons Attribution 4.0 International License.
Licensing Terms
All articles are published under a Creative Commons License and will be directed to the Creative Commons Attribution 4.0 International License (CC BY 4.0) That permits use, distribution, and reproduction in any medium, provided the original work is properly cited. This license also allows the work to be used for commercial purposes.
Use by both non-commercial and commercial users
This content is licensed under a Creative Commons Attribution 4.0 International (CC BY 4.0) license, permitting use by both non-commercial and commercial users. Individual users may access, download, copy, display, and redistribute the articles to colleagues, as well as adapt, translate, and text- and data-mine the content, subject to the following conditions:
- The author's moral rights, including the right of attribution and the right to protect their work from derogatory treatment, are respected.
- Where content in the article is identified as belonging to a third party, users must ensure that any reuse complies with the copyright policies of the owner of that content.
- If the article content is reused for research or educational purposes, users should maintain a link to the appropriate bibliographic citation, including the DOI and a link to the published version on the journal's website.